Cvs Health (CVS) Common Equity (2009 - 2026)

Cvs Health (CVS) has reported Common Equity for 18 consecutive years, with $79.9 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 3.03% year-over-year to $79.9 billion; the trailing twelve-month figure through Jun 2026 stood at $79.9 billion (up 3.03% YoY), and the FY2025 full-year result was $75.4 billion, changed 0.46% from the prior year.
• Common Equity rose to $79.9 billion in Q2 2026 per CVS's latest filing, from $77.6 billion in the prior quarter.
• Across five years, Common Equity topped out at $79.9 billion in Q2 2026 and bottomed at $71.5 billion in Q3 2022.
• Historically, Common Equity has averaged $75.0 billion across 5 years, with a median of $75.1 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Common Equity fell 4.2% in 2022, then gained 6.78% in 2023.
• Over 5 years, Common Equity stood at $71.8 billion in 2022, then grew by 6.78% to $76.6 billion in 2023, then slipped by 1.18% to $75.7 billion in 2024, then dropped by 0.46% to $75.4 billion in 2025, then climbed by 5.99% to $79.9 billion in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $79.9 billion, $77.6 billion, and $75.4 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.